Camber Capital Management LP Novartis Ag Transaction History
Camber Capital Management LP
- $4.32 Billion
- Q4 2024
A detailed history of Camber Capital Management LP transactions in Novartis Ag stock. As of the latest transaction made, Camber Capital Management LP holds 1,000,000 shares of NVS stock, worth $111 Million. This represents 3.01% of its overall portfolio holdings.
Number of Shares
1,000,000Holding current value
$111 Million% of portfolio
3.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding NVS
# of Institutions
1,478Shares Held
130MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.36 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.22 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$909 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$763 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$620 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $239B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...